Back to BlackRock, Inc. BlackRock, Inc.

TXGTXG
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in 10x Genomics Inc Class A

BlackRock, Inc. holds 10.8M shares of TXG (10x Genomics Inc Class A), worth $414.2M as of 2026-Q2. The position was increased (+7.2% shares). TXG represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$414.2M

Current Shares

10.8M

Total Value Change

+$317M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10.8M
+7.2%
$414.2M0.0%$38.34
33
2026-Q1
Increased
10.1M
+0.7%
$214M0.0%$22.62
31
2025-Q4
Increased
10M
+5.9%
$163.3M0.0%$16.29
32
2025-Q3
Increased
9.5M
+0.3%
$110.6M0.0%$11.34
30
2025-Q2
Increased
9.4M
+41.5%
$109.3M0.0%$11.73
40
2025-Q1
Decreased
6.7M
-1.5%
$58.2M0.0%$9.16
0
2024-Q4
New
6.8M
-
$97.2M0.0%$14.35
41

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used